Myeloperoxidase Gene Polymorphism and Heart Disease
Author Information
Author(s): Zhong Chen, Quanzhong Yin, Genshan Ma, Hua Zhang, Ruolong Zheng, Jiahong Wang, Chunheng Gao
Primary Institution: The Affiliated ZhongDa Hospital of Southeast University
Hypothesis
Is there an association between myeloperoxidase gene -463G > A polymorphism and premature coronary artery disease in Chinese populations?
Conclusion
The -463G > A polymorphism of the myeloperoxidase gene is associated with a reduced risk of premature coronary artery disease in Chinese individuals.
Supporting Evidence
- The AA genotype was found to be significantly less frequent in patients with premature CAD compared to controls.
- Carriers of the AA genotype had an 83% reduced risk of premature CAD compared to those with the G/G genotype.
- The study included a total of 459 patients, with 229 diagnosed with premature CAD.
Takeaway
This study found that a specific gene change might help protect some people from getting heart disease at a young age.
Methodology
The study involved genotyping patients and controls using ligase detection reaction and polymerase chain reaction sequencing.
Potential Biases
Potential bias due to the study being limited to a single center and the relatively infrequent AA genotype.
Limitations
The study was conducted at a single hospital, which may not represent the broader population.
Participant Demographics
229 patients with premature CAD (men aged 36-54 years and women aged 39-64 years) and 230 age- and sex-matched controls.
Statistical Information
P-Value
0.002
Confidence Interval
0.057-0.526
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website